Latest Content

Stage 2 lymphoma is treatable. Diagnosis and treatment depend on subtype, but most patients achieve excellent outcomes with modern therapies.

The FDA has approved Revuforj for relapsed or refractory acute myeloid leukemia with an NPM1 mutation.

CURE spoke with Dr. Surbhi Sidana about the recently approved antibody-drug conjugate Blenrep for multiple myeloma.

Dr. Alessandro Gozzetti highlights fertility and reproductive health as often overlooked but vital aspects of survivorship in hairy cell leukemia.

Combining Rituxan with Mavenclad or Zelboraf upfront can extend remissions safely and should become standard first-line therapy for hairy cell leukemia.

The FDA has granted fast track designation to MT-125 for the treatment of patients with glioblastoma.

The FDA approved Blenrep with Velcade and dexamethasone for relapsed or refractory multiple myeloma.

What you need to know about stomach cancer, also known as gastric cancer.

Even after all these years with small lymphocytic lymphoma, I’ve accepted that the scares will never completely go away — but neither will my resilience.

Here is a basic guide to what you need to know about stage 2 papillary thyroid cancer.

What are we supposed to do to be a “true” friend to someone who is facing cancer?

The Food and Drug Administration granted fast track designation to HDP-101 for the treatment of multiple myeloma.

The MELODY study found music therapy to be effective at relieving the anxiety of cancer survivors.